GlaxoSmithKline (GSK) Company
.jpg)
GlaxoSmithKline develops and markets products in the areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.
Technology:
Atrificial Vectors and Immune Cells
Industry:
Atrificial Vectors and Immune Cells
Headquarters:
London, England, United Kingdom
Founded Date:
1929-01-01
Employees Number:
10001+
Funding Status:
IPO
Investors Number:
1
Total Funding:
25000000
Estimated Revenue:
$10B+
Last Funding Date:
2021-03-02
Last Funding Type:
Grant
Register and Claim Ownership